Henry Hoppe, Iv

Title: Henry Hoppe, Iv: Innovator in Mutagenesis Assays

Introduction

Henry Hoppe, Iv is a notable inventor based in Arlington, MA (US). He has made significant contributions to the field of genetic research, particularly in the area of mutagenesis. His work focuses on developing assays that can detect mutagenic damage in human cells.

Latest Patents

Henry Hoppe, Iv holds a patent for an "Assay for mutagenesis in heterozygous diploid human lymphoblasts." This assay is designed to determine mutagenic damage caused by the administration of known or suspected mutagens to diploid human lymphoblastoid cell lines. The assay utilizes gene loci for thymidine kinase, uridine kinase, or cytidine deaminase. By employing heterozygotes of human lymphoblastoid cells, the assay effectively measures mutagenic effects.

Career Highlights

Henry Hoppe, Iv is affiliated with the Massachusetts Institute of Technology, where he continues to advance research in genetic assays. His work has implications for understanding genetic mutations and their effects on human health.

Collaborations

Henry has collaborated with esteemed colleagues such as Thomas R Skopek and Howard L Liber, contributing to the advancement of mutagenesis research.

Conclusion

Henry Hoppe, Iv is a prominent figure in the field of genetic research, with a focus on mutagenesis assays that have the potential to impact medical science significantly. His innovative work continues to pave the way for future discoveries in genetics.